Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03625752 · ClinicalTrials.gov registry record · NA
Optimization of NIBS for Diabetic Neuropathy Neuropathic Pain
A NA study of Chronic Pain and Diabetic Neuropathies, sponsored by Case Western Reserve University.
- Active
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 2
- Study locations
NCT03625752: Active NA study of Chronic Pain and Diabetic Neuropathies, sponsored by Case Western Reserve University.
NCT03625752 is a NA study of Chronic Pain and Diabetic Neuropathies that is active but no longer recruiting, run by Case Western Reserve University. The registered enrollment target is 60 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03625752, a NA study of Chronic Pain and Diabetic Neuropathies, is active but no longer recruiting, sponsored by Case Western Reserve University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to assess the effects of Transcranial Direct Current Stimulation (tDCS) in combination with Transcranial ultrasound (TUS) for the treatment of pain and functional limitations in subjects with Diabetic Neuropathic Pain.
Primary Outcome
The scale will assess a patient's pain intensity on a scale from 0 (no pain) to 10 (worst pain imaginable). Changes in VAS for Pain will be measured to determine whether anodal transcranial direct current stimulation (tDCS) in conjunction with transcranial ultrasound (TUS) (applied in a diagnostic mode) is effective in reducing pain of subjects with diabetic neuropathic pain.
Conditions Studied
Interventions
- DEVICE Sham
- DEVICE Active Comparator: Active tDCS + Active TUS
Study Locations (2)
Illinois
- Ciro Ramos Estebanez - Chicago
Ohio
- University Hospitals Cleveland Medical Center/ Dahms Clinical Research Unit - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2019-06-06 |
| Est. Completion | 2026-05-07 |
| Phase | NA |
What the registry record for NCT03625752 still lists
NCT03625752 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Sham is the first listed.
NCT03625752 reports a single indexed study location in Illinois, Ohio.
Frequently Asked Questions
What is clinical trial NCT03625752 about?
NCT03625752 is a clinical study titled "Optimization of NIBS for Diabetic Neuropathy Neuropathic Pain". The purpose of this study is to assess the effects of Transcranial Direct Current Stimulation (tDCS) in combination with Transcranial ultrasound (TUS) for the treatment of pain and functional limitations in subjects with Diabetic Neuropathic Pain.
What is the current status of trial NCT03625752?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2019-06-06. Estimated completion is 2026-05-07.
What conditions does trial NCT03625752 study?
This clinical trial studies the following conditions: Chronic Pain, Diabetic Neuropathies.
What interventions are being tested in trial NCT03625752?
The interventions under investigation include: Sham (DEVICE), Active Comparator: Active tDCS + Active TUS (DEVICE).
Who is sponsoring clinical trial NCT03625752?
This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03625752 being conducted?
This trial has 2 study locations across Illinois, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03625752's enrollment target sits among peer trials
60 176th of 301 higher than 112 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI